Jacobson Pharma seals $85m IPO on robust demand

By Jonathan Breen
14 Sep 2016

Hong Kong’s Jacobson Pharma Corp has wrapped up bookbuilding for its IPO, bagging HK$659.4m ($85m) following a strong turnout from long-only accounts.

The deal closed on Tuesday, with the issue benefiting from its unique position as the largest supplier of generic drugs to Hong Kong’s Hospital Authority and the discount it offered to other pharmaceutical and healthcare companies in the city.

Sole lead BOC International (BOCI) fired up the transaction ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial